155 related articles for article (PubMed ID: 11716250)
1. Relationship between the QT indices and the microvolt-level T wave alternans in cardiomyopathy.
Kuroda N; Ohnishi Y; Adachi K; Yokoyama M
Jpn Circ J; 2001 Nov; 65(11):974-8. PubMed ID: 11716250
[TBL] [Abstract][Full Text] [Related]
2. Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy.
Adachi K; Ohnishi Y; Shima T; Yamashiro K; Takei A; Tamura N; Yokoyama M
J Am Coll Cardiol; 1999 Aug; 34(2):374-80. PubMed ID: 10440148
[TBL] [Abstract][Full Text] [Related]
3. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study.
Sakabe K; Ikeda T; Sakata T; Kawase A; Kumagai K; Tezuka N; Takami M; Nakae T; Noro M; Enjoji Y; Sugi K; Yamaguchi T
Jpn Heart J; 2001 Jul; 42(4):451-7. PubMed ID: 11693281
[TBL] [Abstract][Full Text] [Related]
4. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and the prognostic value of microvolt T-wave alternans in patients with hypertrophic cardiomyopathy.
Trzos E; Kasprzak JD; Krzemińska-Pakuła M; Rechciński T; Wierzbowska-Drabik K; Uznańska B; Śmiałowski A; Rudziński T; Kurpesa M
Ann Noninvasive Electrocardiol; 2011 Jul; 16(3):276-86. PubMed ID: 21762256
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of T-wave alternans, QT c dispersion and late potential for predicting ventricular tachycardia in patients with ischemic heart disease].
Ohisa N; Ohira M; Mizonobe K; Funato T; Kaku M; Munakata Y
Rinsho Byori; 2002 Feb; 50(2):191-5. PubMed ID: 11925858
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy.
Kuroda N; Ohnishi Y; Yoshida A; Kimura A; Yokoyama M
Circ J; 2002 May; 66(5):457-62. PubMed ID: 12030340
[TBL] [Abstract][Full Text] [Related]
8. Defibillator electrogram T wave alternans as a predictor of spontaneous ventricular tachyarrhythmias in defibrillator recipients.
Kim JW; Pak HN; Park JH; Nam GB; Kim SK; Lee HS; Jang JK; Choi JI; Kim YH
Circ J; 2009 Jan; 73(1):55-62. PubMed ID: 19039191
[TBL] [Abstract][Full Text] [Related]
9. Microvolt T-wave alternans: a review of techniques, interpretation, utility, clinical studies, and future perspectives.
Haghjoo M; Arya A; Sadr-Ameli MA
Int J Cardiol; 2006 May; 109(3):293-306. PubMed ID: 16054250
[TBL] [Abstract][Full Text] [Related]
10. Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.
Suszko A; Nayyar S; Labos C; Nanthakumar K; Pinter A; Crystal E; Chauhan VS
J Am Heart Assoc; 2020 Sep; 9(17):e016461. PubMed ID: 32806990
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans.
Adachi K; Ohnishi Y; Yokoyama M
Jpn Circ J; 2001 Feb; 65(2):76-80. PubMed ID: 11216829
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study.
Hohnloser SH; Klingenheben T; Bloomfield D; Dabbous O; Cohen RJ
J Am Coll Cardiol; 2003 Jun; 41(12):2220-4. PubMed ID: 12821251
[TBL] [Abstract][Full Text] [Related]
13. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy.
Kitamura H; Ohnishi Y; Okajima K; Ishida A; Galeano E; Adachi K; Yokoyama M
J Am Coll Cardiol; 2002 Jan; 39(2):295-300. PubMed ID: 11788222
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of microvolt T-wave alternans in the risk stratification of patients with hypertrophic cardiomyopathy.
Fuchs T; Torjman A
Isr Med Assoc J; 2009 Oct; 11(10):606-10. PubMed ID: 20077947
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.
Momiyama Y; Hartikainen J; Nagayoshi H; Albrecht P; Kautzner J; Saumarez RC; McKenna WJ; Camm AJ
Jpn Circ J; 1997 Aug; 61(8):650-6. PubMed ID: 9276769
[TBL] [Abstract][Full Text] [Related]
16. Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study.
Chauhan VS; Downar E; Nanthakumar K; Parker JD; Ross HJ; Chan W; Picton P
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H79-86. PubMed ID: 16113076
[TBL] [Abstract][Full Text] [Related]
17. Relation between microvolt level T wave alternans and other potential noninvasive predictors of arrhythmic risk in the Marburg Cardiomyopathy Study.
Grimm W; Hoffmann J; Menz V; Maisch B
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1960-4. PubMed ID: 11139967
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing Right Ventricular Cardiomyopathy From Idiopathic Right Ventricular Outflow Tract Tachycardia with T-wave Alternans.
Yalin K; Golcuk E; Aksu T; Tiryakioglu SK; Bilge AK; Adalet K
Am J Med Sci; 2015 Dec; 350(6):463-6. PubMed ID: 26536082
[TBL] [Abstract][Full Text] [Related]
19. T wave alternans for predicting adverse effects of amiodarone in a patient with dilated cardiomyopathy.
Matsuyama T; Tanno K; Kobayashi Y; Obara C; Ryu S; Adachi T; Ezumi H; Asano T; Miyata A; Koba S; Baba T; Katagiri T
Jpn Circ J; 2001 May; 65(5):468-70. PubMed ID: 11348056
[TBL] [Abstract][Full Text] [Related]
20. Exercise recordings for the detection of T wave alternans. Promises and pitfalls.
Albrecht P; Arnold J; Krishnamachari S; Cohen RJ
J Electrocardiol; 1996; 29 Suppl():46-51. PubMed ID: 9238377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
